Moderna (MRNA) News
NASDAQ: MRNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
225.00+28.00 (+14.21%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MRNA news summary
We found 40 recent headlines mentioning Moderna (MRNA): 13 in the past week and 37 in the past 30 days, most often from Nasdaq, Seeking Alpha, Investing.com. MRNA is making an outsized move today, up 14.21% at $225.00, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Why Moderna Stock Surged Today", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Moderna headlines
- Why Moderna Stock Surged TodayKey PointsThe National Institutes of Health (NIH) is reportedly planning to launch a cancer vaccine development program.NasdaqMRNA, MRK, ET
- Moderna gains 14% to set fresh 52-week highSeeking Alpha
- This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall StreetKey PointsModerna has made important pipeline progress this year.NasdaqMRNA, ET
- Noteworthy Friday Option Activity: MRNA, HOOD, TMUSAmong the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Moderna Inc (Symbol: MRNA), where a total of 230,723 contracts have traded so far, representing…NasdaqMRNA, HOOD, TMUS
- Moderna options activity surges as Nasdaq-100 inclusion and melanoma data drive call buyingInvesting.com
- After Hours Most Active for Oct 8, 2026 : MRNA, NVDA, QQQ, INTC, AAPL, TRVIThe NASDAQ 100 After Hours Indicator is up 23.14 to 30,748.95. The total After hours volume is currently 155,853,400 shares traded.The following are the most active stocks for the after hours…NasdaqMRNA, NVDA, QQQ, INTC
- Invesco S&P 500 Equal Weight ETF Experiences Big OutflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Equal Weight ETF (Symbol: RSP) where we have detected…NasdaqRSP, MRNA, PTC, P
- Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?MRNA's Nasdaq-100 entry follows a 566% stock surge and stronger cancer therapy prospects, potentially boosting demand from index-tracking funds.NasdaqMRNA, MRK, SKYD
- Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?Key PointsAxsome Therapeutics is seeing massive revenue growth as it expands its footprint in the central nervous system treatment market.NasdaqAXSM, MRNA
- Is Now the Time to Cash Out of the S&P 500's Top 3 Stocks of 2026?Key PointsShares of Sandisk and Dell Technologies have been flying this year due to surging demand, driven by artificial intelligence.NasdaqSNDK, MRNA, DELL
- State attorneys general sue RFK Jr., seeking to reinstate childhood vaccine scheduleSeeking Alpha
- Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest LosersBiotech stocks took a hit Tuesday, with Vaxcyte, Moderna and Revolution Medicines posting some of the steepest losses. The post Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The…Investor's Business DailyPCVX, MRNA
- Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity?Merck's 7% dip may offer a buying opportunity as Keytruda drives growth and new products and pipeline assets strengthen its post-2028 outlook.NasdaqMRK, AZN, MRNA
- Moderna, Illumina lead healthcare gains in September as medtech dragsSeeking AlphaILMN, MRNA
- Moderna, Illumina lead healthcare gains in September as medtech dragsSeeking AlphaA, ILMN, MRNA
- Moderna, Illumina lead healthcare gains in September as medtech dragsSeeking AlphaTMO, ILMN, MRNA
- Notable analyst calls this week: Target, Moderna and PepsiCo among top picksSeeking AlphaED, PEP, MRNA
- Notable analyst calls this week: Target, Moderna and PepsiCo among top picksSeeking AlphaOXY, PEP, MRNA
- Friday's ETF with Unusual Volume: HTECThe ROBO Global Healthcare Technology and Innovation ETF is seeing unusually high volume in afternoon trading Friday, with over 454,000 shares traded versus three month average volume of about…NasdaqHTEC, BSX, MRNA, QGEN
- Moderna To Join Nasdaq-100, Replacing Warner Bros. Discovery(RTTNews) - On Monday, Nasdaq, Inc (NDAQ) announced that Moderna, Inc (MRNA) will join the Nasdaq-100 Index, replacing Warner Bros. Discovery, before market open on October 9, 2026.NasdaqMRNA, NDAQ
- Moderna (MRNA) Stock Dips While Market Gains: Key FactsModerna (MRNA) closed the most recent trading day at $188.94, moving 1.89% from the previous trading session.Nasdaq
- If I Could Tell Every New Investor 1 Thing About Building Wealth in the Stock Market, It's ThisKey PointsA bull market is a great time to own stocks, as many may soar and will increase the value of your portfolio.NasdaqCOST, AAPL, JNJ, MU
- Prediction: Moderna Stock Will Soar 100% by 2030Key PointsModerna was known for its coronavirus vaccine a few years ago, but it’s greatly expanded its pipeline in recent years.NasdaqMRNA, MRK
- Noteworthy Wednesday Option Activity: NRG, MRNA, TGTAmong the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in NRG Energy Inc (Symbol: NRG), where a total of 16,258 contracts have traded so far,…NasdaqNRG, MRNA, TGT
- Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now?MRNA's respiratory vaccine expansion and promising oncology results offer potential growth as COVID-19 demand normalizes.NasdaqMRNA, BNTX, PFE, MRK
- Moderna Names Juan Andres As Chief Operating Officer(RTTNews) - Moderna, Inc. (MRNA), an mRNA medicine-focused company, announced the creation of a Chief Operating Officer role and Juan Andres will return to Moderna as Chief Operating Officer,…Nasdaq
- Moderna And Merck: The Intismeran Readout That Was Worth $86 BillionSeeking Alpha
- SCHM, BE, COHR, MRNA: Large Outflows Detected at ETFLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab U.S. Mid-Cap ETF (Symbol: SCHM) where we have detected an…NasdaqSCHM, BE, COHR, MRNA
- Moderna vs. BioNTech: Which mRNA Cancer Stock Has More Upside?Moderna (NASDAQ: MRNA) has delivered the pivotal cancer result investors were waiting for, while BioNTech Se (NASDAQ: BNTX) offers greater financial flexibility and a broader oncology pipeline. The…NasdaqBNTX, MRNA
- Biotech Stocks At 52-Week Highs - TKNO, MRNA, ATRC, ILMN(RTTNews) - The following biotech stocks reached a 52-week high on September 23, 2026, driven by key catalysts such as positive quarterly reports or results from clinical trials.NasdaqATRC, ILMN, MRNA, TKNO
- Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum TranscriptSeeking Alpha
- MRNA Hits 52-Week High: How Melanoma Study Results Keep Rally GoingModerna's 52-week high follows positive melanoma results, with detailed phase III data set for an ESMO presentation.NasdaqMRNA, SNY, PFE, MRK
- BioNTech Stock Recently Got Downgraded. But Is Wall Street Underestimating Its Cancer Pipeline?Key PointsBMO Capital Markets downgraded BioNTech and lowered its price target for the stock.NasdaqBNTX, MRK, BMO, MRNA
- Biotech ETFs to Buy as Cancer Drug Breakthroughs AccelerateBiotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.NasdaqAMGN, ILMN, MRNA, HALO
- Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking AlphaMRNA, MS
- The Melanoma Win Is Real, The Price Isn't - Moderna And MRNY Both SellSeeking Alpha
- New FDA Drug Approvals - August 2026(RTTNews) - The U.S. Food and Drug Administration (FDA) granted approval to 13 drugs last month, comprising both new drug approvals and expanded indications for previously approved therapies.NasdaqBMY, BNTX, GILD, JAZZ
- Moderna: Massive Asymmetry About What The mRNA Is!Seeking Alpha
- Weekly Buzz: RARE, REGN Secure FDA Nod, BMRN Stikes Deal; HUMA, EYPT Face Trial Setbacks(RTTNews) - This week's global biopharma roundup captured a mix of regulatory approvals, strategic partnerships, acquisitions, and merger activity, alongside clinical trial breakthroughs and halts.…NasdaqALIT, ARGX, AZN, BMRN
- Pre-Market Most Active for Aug 19, 2026 : CAST, MRNA, SKDD, SKHY, SKUU, MUU, NOK, MRK, STLA, LYG, NIO, PFEThe NASDAQ 100 Pre-Market Indicator is up 99.74 to 29,590.7. The total Pre-Market volume is currently 146,830,338 shares traded.The following are the most active stocks for the pre-market session:…NasdaqCAST, MRNA, MUU, NOK